We have not compared cost between automated and manual processes.  It is possible the overall material cost is higher simply due to consumables cost.  Of course there is also the capital cost of the system itself.  Those costs can be ultimately at least partially offset by reduction in FTEs required to run a cell line development campaign and the potential increase in throughput, either in numbers of clones processed or number of cell line development campaigns initiated.